Back to results
US 2021/0277128 A1Published application
Bispecific Tetravalent Antibodies and Methods of Making and Using Thereof
AssigneesSystimmune, Inc., Sichuan Baili Pharmaceutical Co. Ltd.
InventorsZeren Gao, Phil Tan, Brian R. Kovacevich, Blair R. Renshaw, Jeffrey B. Adamo, Nga Sze Amanda Mak, Shi Zhuo, Lan Chen, Yi Zhu
Life of this patent
Estimating the term…
Abstract
A bispecific tetravalent antibody comprising an IgG having a pair of heavy chains and a pair of light chains, and two scFv components being connected to either C or N terminals of the heavy or light chains. The bispecific tetravalent antibody may have a binding specificity for two different members of EGFR family.
Claims62
A bispecific tetravalent antibody, said bispecific tetravalent antibody comprising:
- two IgG1 heavy chains;
- two kappa light chains;
- and
- two single chain Fv (scFv) domains;
- wherein the two IgG1 heavy chains and kappa light chains form an IgG moiety with a binding specificity to a first member of the EGFR family;
- wherein the two scFv domains have a binding specificity to a second member of the EGFR family, and each scFv domain is connected to the C-terminus of either of the IgG1 heavy chains by a connector with an amino acid sequence of (gly-gly-gly-gly-ser)n, to provide a IgG1-connector connection, wherein n is an integral of at least 1;
- and
- wherein each scFv domain has a structure order of N terminus-variable heavy chain-linker-variable light chain-C terminus or N-terminus-variable light chain-linker-variable heavy chain-C-terminus, and wherein the linker is comprised of amino acid sequence of (gly-gly-gly-gly-ser)m, wherein m is an integral of at least 3.
5 more elements
Dependencies are inferred from the claim text.